AI Robotics in Medicine

AiM Medical Robotics and Siemens Healthineers will build a software interface connecting AiM’s MRI‑compatible stereotactic neurosurgery robot with Siemens’ MAGNETOM systems across 1. 5T, 3T, and 0.

55T (including Free. XL), enabling coordinated, real‑time in‑bore image‑guided procedures from neurostimulator lead placement to ablations, biopsies, and therapeutic delivery.

The collaboration pairs Siemens’ third‑party framework (with exploration of deeper software synchronization and compatibility) with AiM’s push toward clinical deployment, reinforced by its May 2024 Brigham and Women’s validation effort for Parkinson’s DBS—watch for proof of seamless workflow integration and the speed of clinical validation across scanner types.

Tracking: Medicine Robotics · AI Medicine · AI Healthcare

Geography: United States, European Union, United Kingdom, Canada, Israel, Switzerland, Singapore, Japan, South Korea, China, India, San Francisco Bay Area, Boston/Cambridge, New York, London, Berlin, Paris, Tel Aviv, Zurich, Toronto, Singapore, Tokyo, Seoul, Beijing, Shanghai, Shenzhen, Bengaluru

1. AiM Medical to integrate MRI-guided neurosurgery robot with Siemens scanners

AiM Medical Robotics and Siemens Healthineers signed an agreement to build a software interface connecting AiM’s MRI‑compatible stereotactic neurosurgery robot with Siemens’ MAGNETOM MRI systems. The integration spans 1.

5T, 3T, and 0. 55T scanners, including the MAGNETOM Free.

XL, enabling coordinated operation between the robot and MRI. The interface is designed for real-time, in‑bore image‑guided interventions such as neurostimulator lead placement, tumor and epilepsy ablation, biopsies, and therapeutic delivery.

Siemens said it will explore expanded software synchronization and compatibility under its third‑party collaboration framework, while AiM cited the collaboration as accelerating its roadmap toward clinical deployment.

In May 2024, AiM partnered with Brigham and Women’s Hospital to validate its robot for deep‑brain stimulation in Parkinson’s patients.

Key facts:

- AiM and Siemens Healthineers will integrate AiM’s robotic neurosurgery platform with MAGNETOM MRI systems.

- Supported scanners include 1.5T, 3T, and 0.55T models, including MAGNETOM Free.XL.

- Software interface enables data exchange and coordinated, real-time in-bore neurosurgical operation.

- Targeted interventions include lead placement, tumor and epilepsy ablation, biopsies, and therapeutics.

- May 2024: AiM began a deep-brain stimulation study at Brigham and Women’s Hospital.

Why it matters: Linking an MRI‑compatible robot directly with widely deployed Siemens scanners could raise the precision and efficiency of image‑guided neurosurgery by keeping procedures in‑bore and synchronized to live imaging.

Hospitals using MAGNETOM systems gain a clearer path to adopt MRI‑guided robotic workflows for DBS, tumor, and epilepsy care.

The collaboration signals growing standardization between robotics and imaging ecosystems, with Siemens’ third‑party framework potentially easing broader interoperability.

Watch for clinical validation data from Brigham and Women’s and signs of deeper software synchronization, which would indicate readiness for broader clinical deployment.

Mpo MagMedicaldevice Network